-
T. pallidum, ROS, and Hepatocyte Apoptosis
2026-08-20
The reference study identifies mitochondrial reactive oxygen species (ROS) accumulation as a central mechanism linking Treponema pallidum exposure to cardiolipin peroxidation, mitochondrial dysfunction, and intrinsic apoptosis in hepatocytes. Its dose-response design and ROS-inhibition experiments provide a mechanistic framework for studying syphilis-associated liver injury, while also highlighting the value of ATP and mitochondrial measurements as complementary functional readouts.
-
miR-3180 Rewires Lipid Metabolism in HCC
2026-08-20
Hong et al. identify miR-3180 as a coordinated regulator of fatty-acid synthesis and uptake in hepatocellular carcinoma, acting through SCD1 and CD36. The study links reduced miR-3180 expression with aggressive tumor behavior and poorer prognosis, while combining patient-tissue analysis, cellular assays, and xenograft validation to support a mechanistic model.
-
SN-38, FUBP1, and FUSE: A Mechanistic Study
2026-08-19
The reference study identifies SN-38, the active metabolite of irinotecan, as an inhibitor of the FUBP1–FUSE DNA interaction in addition to its established topoisomerase I activity. Its screening, biochemical, and cellular data suggest that disrupting FUBP1-dependent transcription may contribute to camptothecin and SN-38 activity in hepatocellular carcinoma, while also providing a testable framework for related cancer models.
-
Metal-Chelating l-Phe Nanostructures Sensitize ICB
2026-08-19
This Nature Nanotechnology study introduces metal-ion-chelating l-phenylalanine nanostructures that reprogram dendritic-cell electrophysiology and remodel immunosuppressive tumour microenvironments. By combining these structures with short-term starvation, the authors enhanced dendritic-cell maturation and tumour-specific cytotoxic T-cell responses, improving the rationale for combination immune checkpoint blockade.
-
BRD4–RAC1 Co-targeting in Breast Cancer
2026-08-18
The reference study shows that simultaneous inhibition of BRD4 and RAC1 suppresses breast-cancer growth, migration, stem-like traits, and xenograft tumorigenesis across molecular subtypes. Its mechanistic contribution is the connection of BRD4–RAC1 blockade to the c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin regulation, providing a framework for evaluating combinatorial cancer epigenetics strategies.
-
BRD4–RAC1 Co-Targeting in Breast Cancer
2026-08-18
The reference study identifies combined BRD4 and RAC1 inhibition as a context-dependent strategy that suppresses growth, stemness, migration, and tumorigenesis across major breast cancer subtypes. Its mechanistic contribution is the connection of dual pathway inhibition to the c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin regulation, providing a framework for interpreting combination treatments in heterogeneous breast cancer.
-
Annexin V-APC/7-AAD Apoptosis Kit Guide
2026-08-17
Build a rapid apoptosis and necrosis detection workflow for PAD4 inhibitor studies, tumor models, and immune-cell co-cultures. This guide explains how dual Annexin V-APC and 7-AAD staining distinguishes phosphatidylserine exposure from membrane failure, while highlighting controls, gating, and troubleshooting for reliable flow cytometry data.
-
Hypoxia and Immunometabolism in Tumors
2026-08-17
This 2025 Cancer Letters review explains how oxygen limitation and nutrient competition jointly reprogram tumor and immune-cell metabolism in the tumor microenvironment. Its main practical contribution is a systems-level framework connecting HIF signaling, glucose use, immune dysfunction, and therapeutic resistance, while highlighting experimental variables that should be controlled in translational models.
-
Deferasirox: Oral Iron Chelator Mechanisms
2026-08-16
Deferasirox is an oral iron chelator that binds trivalent iron and supports research on iron overload, lysosomal iron handling, and cancer biology. The TCF25 study provides a mechanistic framework for glucose-starvation-induced ferritinophagy and lysosomal cell death, but it did not directly test deferasirox.
-
Olfr110 Structures Reveal Fatty Acid Odor Sensing
2026-08-15
Han et al. use cryo-electron microscopy to define how the class II olfactory receptor Olfr110 recognizes hydrophobic unsaturated fatty acid metabolites and couples ligand binding to G-protein activation. The study identifies a large, chemically heterogeneous binding pocket, conserved recognition motifs, and an activation pathway that differs from canonical class A GPCRs, providing a structural framework for interpreting fatty acid odor detection.
-
2'3'-cGAMP for STING Assay Design
2026-08-14
Use 2'3'-cGAMP (sodium salt) as a direct, high-affinity STING stimulus to separate cGAS, STING, TBK1, and IRF3 effects in innate immune assays. This workflow combines pathway benchmarking with a practical strategy for investigating REC8-dependent antiviral signaling and translational immunotherapy research.
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-08-14
The reference study identifies O-GlcNAcylation as a metabolic effector of Wnt-stimulated osteogenesis, linking Wnt signaling to aerobic glycolysis through stabilization of PDK1 at Ser174. Its combination of temporal signaling analysis, lineage-specific genetics, metabolic measurements, and bone-healing models provides a mechanistic framework for studying glucose metabolism in bone formation.
-
RRP Restores Lipid Metabolism in HIRI
2026-08-13
A Journal of Ethnopharmacology study shows that Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury by coordinating AMPK activation, suppression of SCAP-SREBP2 cholesterol synthesis, and LXRα-dependent cholesterol efflux. Its oleic acid–palmitic acid hepatocyte model provides a useful framework for studying lipotoxicity, while the mouse data connect lipid remodeling with tissue protection.
-
Resibufogenin Blocks NLRP3 in Atherosclerosis
2026-08-13
The reference study identifies resibufogenin as a potential anti-atherosclerotic agent that acts by interfering with NLRP3 inflammasome assembly rather than solely modifying lipid metabolism. Using ApoE-/- mice, macrophage-based cellular models, molecular docking, and surface plasmon resonance, the authors connect RBG binding at NLRP3 CYS-279 with reduced inflammation, foam-cell formation, and plaque pathology.
-
T. pallidum, Mitochondrial ROS, and Hepatocyte Apoptosis
2026-08-12
This study identifies mitochondrial reactive oxygen species accumulation and cardiolipin peroxidation as central features of Treponema pallidum-induced intrinsic apoptosis in hepatocytes. Its combination of apoptosis, mitochondrial function, ATP, ROS, and cardiolipin readouts provides a useful framework for dissecting infection-associated liver injury while highlighting the need for validation beyond an immortalized cell model.